David Miller to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications David Miller has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.020
-
Bradbury PA, Heist RS, Kulke MH, Zhou W, Marshall AL, Miller DP, Su L, Park S, Temel J, Fidias P, Sequist L, Lynch TJ, Wain JC, Shepherd FA, Christiani DC, Liu G. A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. Cancer Epidemiol Biomarkers Prev. 2008 Jan; 17(1):204-11.
Score: 0.020